NDC 72196-0425

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC
72196-0425
Product root
72196-0425
Identity scope
Product
Primary current NDC product row
Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
compounderpackage72196-042572196-0425-1COMPOUNDEROutsourcing facility compounded drug report2023-22025-09-25
compounderpackage72196-042572196-0425-1COMPOUNDEROutsourcing facility compounded drug report2023-22026-09-09

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopeProduct NDCPackage NDCCodeStatusReporting periodArchiveSnapshotSource SHA-256
2025-12-16 00:49 UTC · source 2025-09-25compounderpackage72196-042572196-0425-1COMPOUNDEROutsourcing facility compounded drug report2023-2compounder / compounders_ndc_directory.zip3f6f48d8db7b…6316a3eebc6a…
2025-08-27 00:00 UTC · source 2025-08-20compounderpackage72196-042572196-0425-1COMPOUNDEROutsourcing facility compounded drug report2023-2compounder / compounders_ndc_directory.zipaf8e9b524e63…ca326a94a5e9…
2025-01-13 04:20 UTC · source 2024-11-20compounderpackage72196-042572196-0425-1COMPOUNDEROutsourcing facility compounded drug report2023-2compounder / compounders_ndc_directory.zip85f958c8d153…997044a9741e…

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCProductActive ingredientsReporting periodNormalization
Central Admixture Pharmacy Services, Inc.72196-042572196-0425-1Trophamine 2% / Dextrose 10% With Calcium Gluconate 2.33mEq and Heparin 125 units 250ml in 250ml bag.27 g/250 mL; .18 g/250 mL; .24 g/250 mL; .1 g/250 mL; .39 g/250 mL; 125 U/250 mL; .6 g/250 mL; .19 g/250 mL; .25 g/250 mL; .022 g/250 mL; .12 g/250 mL; .21 g/250 mL; .012 g/250 mL; .24 g/250 mL; .6 g/250 mL; .0125 g/250 mL; 25 g/250 mL; 2.33 meq/250 mL; .7 g/250 mL; .17 g/250 mL; .34 g/250 mL; .16 g/250 mL; .41 g/250 mL2023-2valid
Central Admixture Pharmacy Services, Inc.08095536672196-042572196-0425-1Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine.27 g/250 mL; .18 g/250 mL; .24 g/250 mL; .1 g/250 mL; .39 g/250 mL; 125 U/250 mL; .6 g/250 mL; .19 g/250 mL; .25 g/250 mL; .022 g/250 mL; .12 g/250 mL; .21 g/250 mL; .012 g/250 mL; .24 g/250 mL; .6 g/250 mL; .0125 g/250 mL; 25 g/250 mL; 2.33 meq/250 mL; .7 g/250 mL; .17 g/250 mL; .34 g/250 mL; .16 g/250 mL; .41 g/250 mL2023-2valid